Wolf A
Br J Cancer. 1978 Jun;37(6):1046-52. doi: 10.1038/bjc.1978.152.
A fraction showing tumour-associated antigenic properties has been isolated from pleural effusions of patients with squamous-cell carcinoma of the lung. Purification of the material was accomplished by ion-exchange and affinity chromatography, and by immunoabsorbents. The antigenic activity was monitored by its inhibitory capacity in a specific complement-dependent cytotoxic system. The final fraction has a mol. wt. of approximately 1.7 X 10(5), as judged by gel filtration on Sephadex G200, and the main component appears to be a glycoprotein with N-acetyl-D-glucosamine groups. The most purified antigen preparation exhibited a highly selective capacity to inhibit in the cytotoxic assay and to bind, when labelled with 125I, to 2 specific antisera. The active fractions isolated from pleural effusions fully crossreacted with fractions prepared from squamous-cell carcinoma extracts. CEA and bacterial antigens were not detected in the material, and the presence of alpha-fetoprotein, HLA and blood-group antigens may be ruled out on account of their respective molecular weights.
从肺癌鳞状细胞癌患者的胸腔积液中分离出了一种具有肿瘤相关抗原特性的组分。该物质通过离子交换、亲和层析以及免疫吸附剂进行纯化。通过其在特定补体依赖性细胞毒性系统中的抑制能力来监测抗原活性。经Sephadex G200凝胶过滤判断,最终组分的分子量约为1.7×10⁵,主要成分似乎是一种带有N-乙酰-D-葡萄糖胺基团的糖蛋白。最纯的抗原制剂在细胞毒性试验中表现出高度的选择性抑制能力,用¹²⁵I标记后能与2种特异性抗血清结合。从胸腔积液中分离出的活性组分与从鳞状细胞癌提取物中制备的组分完全交叉反应。在该物质中未检测到癌胚抗原(CEA)和细菌抗原,鉴于其各自的分子量,可排除甲胎蛋白、人类白细胞抗原(HLA)和血型抗原的存在。